The #FDA has issued updated #guidance that aims to make it easier for drugmakers to bring #biosimilars of patent-expired #biologicdrugs to market, in the hope of reducing medicine #prices.

pharmaphorum.com/home/fda-cut...

FDA plan will cut testing requirements for biosimilars The FDA has proposed a radical change to the regulatory requirements for bringing biosimilar medicines to market as a way to cut US drug prices.

The #FDA has proposed a radical change to the #regulatory requirements for bringing #biosimilars to market, in a bid to accelerate the rollout of cheaper versions of off-patent #biologicdrugs.

pharmaphorum.com/news/fda-pla...